These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1134450)

  • 1. [Prevention of neonatal hyperbilirubinemia by enzyme inducers. Effectiveness of a phenobarbital-nikethamide association].
    Patriarca PL; Peracino A; Marcovina S; Zecca G
    Minerva Pediatr; 1975 Apr; 27(14):865-73. PubMed ID: 1134450
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevention of toxic hyperbilirubinemia in premature and mature newborn infants by use of an enzyme-inducing combination: phenobarbital-nikethamide].
    Kintzel HW
    Helv Paediatr Acta; 1973; 30():Suppl:35-7. PubMed ID: 4711239
    [No Abstract]   [Full Text] [Related]  

  • 3. [Synergistic effect of combined enzyme inductors (Phenobarbital and Nikethamide) on the bilirubin concentration in the serum of newborn infants].
    Kintzel HW; Schwarze R; Hinkel GK
    Dtsch Gesundheitsw; 1971 Dec; 26(51):2424-8. PubMed ID: 5148595
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevention of hyperbilirubinemia in premature infants using a combination of two enzyme inductors: phenobarbitol and nikethamide].
    Hinkel GK; Kintzel HW; Schwarze R; Händel A
    Dtsch Gesundheitsw; 1972 Sep; 27(39):1854-7. PubMed ID: 4634399
    [No Abstract]   [Full Text] [Related]  

  • 5. An enzyme inductor combination for the prevention of hyperbilirubinemia in premature infants.
    Hinkel GK; Kintzel HW; Schwarze R; Händel A
    Acta Paediatr Scand; 1974 May; 63(3):393-7. PubMed ID: 4838967
    [No Abstract]   [Full Text] [Related]  

  • 6. [Dynamic changes in the level of serum bilirubin in newborn infants treated with enzyme inducers].
    Daskalova E; Tsankova TS
    Akush Ginekol (Sofiia); 1977; 16(1):66-72. PubMed ID: 324302
    [No Abstract]   [Full Text] [Related]  

  • 7. [Preventive drug therapy of hyperbilirubinemia in full-term infants].
    Langer P; Berg G; Endig W
    Kinderarztl Prax; 1977 Jan; 45(1):11-4. PubMed ID: 556483
    [No Abstract]   [Full Text] [Related]  

  • 8. [Practical procedure in the prophylaxis and therapy of hyperbilirubinemia in the newborn infant].
    Kunze W; Joppien HG
    Z Arztl Fortbild (Jena); 1981 Feb; 75(3):108-10. PubMed ID: 7281734
    [No Abstract]   [Full Text] [Related]  

  • 9. [Enzyme inductors in the treatment of neonatal hyperbilirubinemia].
    Daskalova E
    Akush Ginekol (Sofiia); 1977; 16(3):213-9. PubMed ID: 331988
    [No Abstract]   [Full Text] [Related]  

  • 10. [Drug therapy in the prevention of transitory hyperbilirubinemia in premature newborn infants].
    Reineke J
    ZFA (Stuttgart); 1976 May; 52(13):681-2. PubMed ID: 1274416
    [No Abstract]   [Full Text] [Related]  

  • 11. [Drug prevention of hyperbilirubinemia in newborn infants. 5. Cumulative effect of the combination of the inductors phenobarbital and nikethamide].
    Gmyrek D; Weh L; Kalz M; Bunke H; Cario WR; Lindenau E; Neumann R; Pietsch I; Scigalla P; Sima K; Syllm-Rapoport I
    Dtsch Gesundheitsw; 1972 Nov; 27(47):2221-7. PubMed ID: 4662684
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prevention of transitory hyperbilirubinemia of the premature and mature newborn infants and of the hemolytic disease of the newborn by an enzyme induction combination: phenobarbital-nikethamide].
    Kintzel HW; Schwarze R; Hinkel GK
    Schweiz Med Wochenschr; 1972 Sep; 102(38):1339-45. PubMed ID: 4630163
    [No Abstract]   [Full Text] [Related]  

  • 13. [Neonatal icterus due to hepatic immaturity].
    Chevrel B; Hecht Y
    Presse Med (1893); 1971 Apr; 79(20):929-30. PubMed ID: 4326050
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prevention of morbus haemolyticus neonatorum and of transitory hyperbilirubinemias of newborn infants through an enzyme inductor combination].
    Kintzel HW
    Blut; 1973 May; 26(5):297-302. PubMed ID: 4196748
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prevention of newborn infant hyperbilirubinemia by use of drugs. 8. Recommendation for the use of prevention in combination with a screening test for prognosis].
    Gmyrek D; Bunke H; Cario WR; Daberkow H; Läuter J; Saworra H; Weh L; Syllm-Rapoport I
    Kinderarztl Prax; 1973 Apr; 41(4):174-90. PubMed ID: 4731678
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacologic treatment of neonatal hyperbilirubinemia.
    Vaisman SL; Gartner LM
    Clin Perinatol; 1975 Mar; 2(1):37-57. PubMed ID: 1102218
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prevention to newborn hyperbilirubinemia through drugs in combination with screening for early prognosis].
    Ivicic L; Palkovicová A; Pramuk V; Reichel F; Rybáková V; Vasil J
    Cesk Pediatr; 1976 May; 31(5):259-61. PubMed ID: 1277391
    [No Abstract]   [Full Text] [Related]  

  • 18. [Phenobarbital in neonatal jaundice].
    Hosková A
    Cesk Pediatr; 1971 Aug; 26(8):390-1. PubMed ID: 5095995
    [No Abstract]   [Full Text] [Related]  

  • 19. [Dangers and potential uses of enzyme stimulating medication on newborns and infants].
    Windorfer A
    Padiatr Padol; 1972; 7(3):246-52. PubMed ID: 5066482
    [No Abstract]   [Full Text] [Related]  

  • 20. [Stimulation of the microsomal enzyme system as a therapeutic principle in the newborn infant].
    Windorfer A
    Med Klin; 1974 May; 69(21):937-41. PubMed ID: 4602287
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.